European Finance News

Readsoft AB (STO:RSOFB) ReadSoft Closes Deals Totaling US$510,000 To End The 2008 Year In Australia

🕔1/5/2009 8:05:00 PM

Readsoft AB (STO:RSOFB) ReadSoft closes two large document automation projects in Australia to end the 2008 year. The combined value is more than US$510,000 and the implementations will be carried out in the first quarter this year. The orders include solutions for accounts payable automation and enterprise wide automation in the insurance sector.

Lesen Sie die komplette Artikel

Songa Offshore SE (OSL:SONG) Fleet Update

🕔1/5/2009 6:59:00 PM

Songa Offshore SE (OSL:SONG) Songa Venus has achieved operating efficiency of 95% in December. The rig is still operating for Santos, currently expected to continue until 7 January, at which time the rig will transfer to the ADA consortium contract, still in Australia.

Lesen Sie die komplette Artikel

TGS-NOPEC (OSL:TGS) TGS Announces New 3D Project In Central And Eastern Gulf Of Mexico

🕔1/5/2009 5:53:00 PM

TGS-NOPEC (OSL:TGS) Asker, Norway, Houston, Texas (January 5, 2009) - TGS-NOPEC Geophysical Company (TGS) announced today that it is acquiring a new Multi-Client 3D survey in the DeSoto Canyon area of the Gulf of Mexico. Named "Hernando", the new survey covers a 300 OCS block (6,900 sq. km) area.

Lesen Sie die komplette Artikel

Crew Gold Corporation (OSL:CRU) Notification Of Trade For Brian Hosking

🕔1/5/2009 5:33:01 PM

Crew Gold Corporation (OSL:CRU) Corporate news announcement processed and transmitted by Hugin AS. The issuer is solely responsible for the content of this announcement. ---------------------------------------------------------------------- --------------

Lesen Sie die komplette Artikel

Galapagos NV (EBR:GLPG) Galapagos Selects Pre-clinical Candidate Drug For Cachexia

🕔1/5/2009 5:33:00 PM

Galapagos NV (EBR:GLPG) Mechelen, Belgium and Biocitech Park, Romainville, France; 5 January 2009 - Galapagos NV (Euronext: GLPG) announced today that it has selected a candidate drug to enter into pre-clinical development in the Company's cachexia (loss of weight and muscle mass) program. This candidate drug is a small molecule that Galapagos has developed in its Selective Androgen Receptor Modulator (SARM) program and which has demonstrated successful Proof of Concept in animal studies.

Lesen Sie die komplette Artikel

Scorpion Offshore Ltd. (OSL:SCORE) - Mandatory Notification Of Trade

🕔1/3/2009 4:55:00 AM

Scorpion Offshore Ltd. (OSL:SCORE) 02 January 2009 Restricted shares vesting on 01 January 2009 were sold by primary insiders to settle US tax liabilities.

Lesen Sie die komplette Artikel

SpareBank 1 Nord-Norge (OSL:NONG) NONG - Mandatory Notification Of Trade

🕔1/3/2009 1:59:00 AM

SpareBank 1 Nord-Norge (OSL:NONG) SpareBank 1 Nord-Norge has 30.12.2008 via Oslo Børs sold 356.000 shares in Hurtigruten ASA (HRG). Average selling price was NOK 3.06. The Bank's new shareholding in HRG is 2 513 413 shares, corresponding to an ownership share of 9.1 %.

Lesen Sie die komplette Artikel